Notably, in thioacetamide‐induced liver fibrosis model, treatment with dasatinib restores WIF‐1 expression via miR‐17 downregulation, suppressing Wnt/β‐catenin and downstream TGFβ/Smad pathways [173]. This evidence concerns the gene TGFB1 and Hepatic fibrosis.